Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.36 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2961470 | 0.77 | CYP3A4 (0.36) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL8919335 | 0.76 | CYP3A4 (0.44) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL3472967 | 0.75 | APP (0.59) | RAB9AMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL21110943 | 0.75 | CA12 (0.40) | CYP2A6ALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL147151 | 0.67 | HSD17B1 (0.48) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL3931046 | 0.67 | SMN1; SMN2 (0.38) | CYP2A6CYP2B6CYP2E1RAB9AMEN1 | |
| SCHEMBL498650 | 0.66 | HSD17B1 (0.65) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL6015219 | 0.65 | RXFP1 (0.53) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL2241368 | 0.64 | HSD17B1 (0.62) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL7591649 | 0.64 | HSD17B1 (0.62) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0423127-A1 | NOVEL PHOTOACTIVE COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND INTERMEDIATES THEREFOR | TRAQSON LIMITED (GB) | 1991-04-24 | — | — | EP | claimed |
| EP-0334477-A2 | Novel photoactive compounds, processes for their production and intermediates therefor | MTM RESEARCH CHEMICALS LIMITED (GB) | 1989-09-27 | — | — | EP | claimed |
| WO-1989007597-A2 | NOVEL PHOTOACTIVE COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND INTERMEDIATES THEREFOR | TRAQSON LIMITED (GB) | 1989-08-24 | — | — | WO | claimed |
| US-20030212116-A1 | Heterocyclic imino compounds and fungicides and insecticides for agricultural and horitcultural use | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-11-13 | — | — | US | disclosed |
| EP-1243580-A1 | HETEROCYCLIC IMINO COMPOUNDS AND FUNGICIDES AND INSECTICIDES FOR AGRICULTURAL AND HORTICULTURAL USE | Nissan Chemical Industries, Ltd. (JP) | 2002-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212116-A1 | Heterocyclic imino compounds and fungicides and insecticides for agricultural and horitcultural use | DDT, CBR3, CYP1B1 | CYP2A6 217/4885CYP2B6 98/4885CYP2E1 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.